Clinical Trials in Los Angeles

Showing 9881-9900 of 14,465 trials

Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection

NCT00513461

This randomized phase II trial studies how well S-Adenosyl-L-Methionine Disulphate P-Toluene-Sulfonate (SAMe) works compared to a placebo in preventing liver cancer in patients with chronic hepatitis C infection. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of SAMe may keep cancer from forming in patients with advanced liver disease

Adult Primary Liver CancerHepatitis C Infection

Chao Family Comprehensive Cancer Center110 participantsStarted Oct 2007

Tucson, Arizona, United States • Long Beach, California, United States • Los Angeles, California, United States +2 more locations

COMPLETEDPhase 3< 1 mile

A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

NCT01473420

The purpose of this study is to demonstrate therapeutic equivalence of subcutaneous (SC) Epoetin Hospira compared to SC Epogen (Amgen), based on maintenance of hemoglobin (Hb) levels and study drug dose requirements in patients treated for anemia associated with chronic renal failure and on hemodialysis.

Chronic Renal FailureChronic Kidney Disease

Pfizer320 participantsStarted Jan 2012

Azusa, California, United States • Bakersfield, California, United States • Long Beach, California, United States +70 more locations

Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection

A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

Find Trials by Condition in Los Angeles

Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus

A Placebo Controlled Study of MR901 (Talaporfin Sodium Sodium + a Drug-activating Device) for the Relief of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents

Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract

6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old

A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD

SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.

S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women

Pilot Study of X-82 in Patients With Wet AMD

Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers

Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer

Smoking Cessation Study In Healthy Adolescent Smokers

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma

Evaluation of HemoTypeSC as a Novel Rapid Test for Point-of-Care Screening for Sickle-Cell Disease, Hemoglobin C Disease, and Carrier Status in Low-Resource Settings

Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder

Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal Insufficiency

Shared Decision Making in the Emergency Department: Chest Pain Choice Trial